127 related articles for article (PubMed ID: 38696075)
1. An atypical adverse reaction to iron infusion: a case report.
Belviso F; Marcianò T; Silva M
Intern Emerg Med; 2024 May; ():. PubMed ID: 38696075
[No Abstract] [Full Text] [Related]
2. Analysis of Adverse Events and Intravenous Iron Infusion Formulations in Adults With and Without Prior Infusion Reactions.
Arastu AH; Elstrott BK; Martens KL; Cohen JL; Oakes MH; Rub ZT; Aslan JJ; DeLoughery TG; Shatzel J
JAMA Netw Open; 2022 Mar; 5(3):e224488. PubMed ID: 35353168
[TBL] [Abstract][Full Text] [Related]
3. Safety profiles of total dose infusion of low-molecular-weight iron dextran and high-dose iron sucrose in renal patients.
Atalay H; Solak Y; Acar K; Govec N; Turk S
Hemodial Int; 2011 Jul; 15(3):374-8. PubMed ID: 21564503
[TBL] [Abstract][Full Text] [Related]
4. Rhabdomyolysis after Intravenous Ferric Gluconate: A Case Report.
Botti M; Piperno A; Cianflone A; Mariani R
Eur J Case Rep Intern Med; 2022; 9(4):003325. PubMed ID: 35520364
[TBL] [Abstract][Full Text] [Related]
5. Symptomatic hypophosphataemia after intravenous iron therapy: an underrated adverse reaction.
Ifie E; Oyibo SO; Joshi H; Akintade O
Endocrinol Diabetes Metab Case Rep; 2019 Aug; 2019(1):. PubMed ID: 31385673
[TBL] [Abstract][Full Text] [Related]
6. Same Day Infusion of Iron Therapy Is Associated With No Increased Risk for Adverse Events Among Patients Receiving Biological Infusions for Inflammatory Bowel Disease.
Reddy S; Shore B; Abramson L; Herfarth HH; Barnes EL
J Clin Gastroenterol; 2022 Oct; 56(9):e318-e322. PubMed ID: 35862033
[TBL] [Abstract][Full Text] [Related]
7. Safety and efficacy of total-dose infusion of low molecular weight iron dextran for iron deficiency anemia in patients with inflammatory bowel disease.
Koutroubakis IE; Oustamanolakis P; Karakoidas C; Mantzaris GJ; Kouroumalis EA
Dig Dis Sci; 2010 Aug; 55(8):2327-31. PubMed ID: 19834803
[TBL] [Abstract][Full Text] [Related]
8. Safety of Intravenous Iron Following Infusion Reactions.
Stojanovic S; Graudins LV; Aung AK; Grannell L; Hew M; Zubrinich C
J Allergy Clin Immunol Pract; 2021 Apr; 9(4):1660-1666. PubMed ID: 33248279
[TBL] [Abstract][Full Text] [Related]
9. An atypical presentation of endometrial cancer as angina secondary to critically low hemoglobin and iron deficiency associated pancytopenia: A case report.
Crawford G; Bahabri A; P'ng S
Case Rep Womens Health; 2023 Jun; 38():e00509. PubMed ID: 37180555
[TBL] [Abstract][Full Text] [Related]
10. Pulmonary edema: atypical anaphylactoid reaction to intravenous iron dextran.
Freter S; Davidman M; Lipman M; Bercovitch D
Am J Nephrol; 1997; 17(5):477-9. PubMed ID: 9382172
[TBL] [Abstract][Full Text] [Related]
11. Safety of iron polymaltose given as a total dose iron infusion.
Newnham E; Ahmad I; Thornton A; Gibson PR
Intern Med J; 2006 Oct; 36(10):672-4. PubMed ID: 16958647
[TBL] [Abstract][Full Text] [Related]
12. Safety profile of iron polymaltose infusions.
Lee AYS; Leung SHP
Hosp Pract (1995); 2019 Apr; 47(2):96-98. PubMed ID: 30882255
[TBL] [Abstract][Full Text] [Related]
13. Skin Staining Following Intravenous Iron Extravasation in a Patient With Chronic Kidney Disease: A Case Report.
Shi R; Marin JG; Beaulieu M
Can J Kidney Health Dis; 2023; 10():20543581231165705. PubMed ID: 37101846
[TBL] [Abstract][Full Text] [Related]
14. Adverse Reactions After Intravenous Iron Infusion Among Inflammatory Bowel Disease Patients in the United States, 2010-2014.
Akhuemonkhan E; Parian A; Carson KA; Hutfless S
Inflamm Bowel Dis; 2018 Jul; 24(8):1801-1807. PubMed ID: 29669068
[TBL] [Abstract][Full Text] [Related]
15. Intravenous Iron Therapy: Re-administration after Prior Adverse Reaction.
Aung T; Thein H; Aung ST; Soe BTA; Ohnmar E
Korean J Fam Med; 2023 Nov; 44(6):350-354. PubMed ID: 37599005
[TBL] [Abstract][Full Text] [Related]
16. The Effects of Intravenous Iron Infusion on Preoperative Hemoglobin Concentration in Iron Deficiency Anemia: Retrospective Observational Study.
Nicholls G; Mehta R; McVeagh K; Egan M
Interact J Med Res; 2022 Feb; 11(1):e31082. PubMed ID: 35113024
[TBL] [Abstract][Full Text] [Related]
17. Safety of high-dose iron sucrose infusion in hospitalized patients with chronic kidney disease.
Hollands JM; Foote EF; Rodriguez A; Rothschild J; Young S
Am J Health Syst Pharm; 2006 Apr; 63(8):731-4. PubMed ID: 16595812
[TBL] [Abstract][Full Text] [Related]
18. Osteomalacia as a Complication of Intravenous Iron Infusion: A Systematic Review of Case Reports.
Vilaca T; Velmurugan N; Smith C; Abrahamsen B; Eastell R
J Bone Miner Res; 2022 Jun; 37(6):1188-1199. PubMed ID: 35426179
[TBL] [Abstract][Full Text] [Related]
19. Administration of intravenous iron through a home-based infusion strategy is safe and has high patient acceptance.
Liu D; Atienza E; Santamaria L; Sinnappu R; Garg M
Intern Med J; 2024 Jan; 54(1):104-107. PubMed ID: 36938780
[TBL] [Abstract][Full Text] [Related]
20. Estimation of the utilities of attributes of intravenous iron infusion treatment for patients with iron-deficiency anemia: a conjoint analysis in Japan.
Takeshima T; Ha C; Iwasaki K
J Med Econ; 2023; 26(1):84-94. PubMed ID: 36519281
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
